Business Description
Inventiva S.A. is a French pharmaceutical company founded in 2011 that creates pill-based treatments for serious diseases, with operations extending beyond France to international markets. Its most advanced drug, Lanifibranor, is currently being tested in a large-scale clinical trial as a potential treatment for a severe liver condition known as MASH, while a second drug, Odiparcil, targets a rare inherited disorder affecting the body's ability to break down certain sugars. The company is also in the early stages of researching a treatment for a progressive lung disease called idiopathic pulmonary fibrosis.
